Articles > Popular publications > PR Newswire press releases > October-December 2008 > Friday, October 10

Article: TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System.

Article from:
PR Newswire
Article date:
October 10, 2008
Copyright

PLEASANTON, Calif., Oct. 10 /PRNewswire/ -- TriReme Medical Inc. (TMI) announced today that it has been authorized to affix the CE (Conformite Europeenne) marking and commercialize in Europe the Antares(TM) Coronary Stent System, a unique main vessel stent system specially designed for use at or near coronary bifurcations.

Representing the next generation in bifurcation stenting, the Antares(TM) system has potential use in a quarter of the 2.2 million angioplasty procedures performed annually worldwide. Antares(TM) stents are not yet approved in the United States and are limited by Federal law to investigational use.

"We are very pleased to achieve ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: TriReme Medical Inc. Announces $15.5 Million Series ...
PR Newswire;  October 16, 2007 ;     673 words ... ... PRNewswire/ -- TriReme Medical Inc. (TMI ... company's novel stent system and to support ... balloon bifurcation stent system that provides ... lesions." About TriReme Medical Inc. TriReme Medical Inc. is a privately ...

Article: TriReme Medical, Inc. Receives CE Marking for ...
PR Newswire;  July 30, 2009 ;     700+ words ... ... coronary bypass surgery. About TriReme Medical, Inc. TriReme Medical, Inc. (TMI) is a privately ... mark for its Antares SX stent system. Antares is a main vessel ... trirememedical.com. CONTACT: TriReme Medical, Inc., +1-925-931 ...

Article: TriReme Medical, Inc. Receives CE Marking for ...
Heart Disease Weekly;  August 16, 2009 ;     685 words ...TriReme Medical, Inc. (TMI) announced CE mark ... follows the success of our Antares stent system and is another important product in ... Surgery, Surgical Technology, TriReme Medical Inc. This article was prepared by ...

Article: TriReme Medical Inc. Secures $15.5 Million in ...
Wireless News;  October 22, 2007 ;     503 words ... ... News 10-22-2007 TriReme Medical Inc. Secures $15 ... October 22, 2007-TriReme Medical Inc. Secures $15 ... 10meters.com TriReme Medical Inc. (TMI), a ... company's novel stent system and to support ongoing ...

Article: Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting ...
PR Newswire;  January 11, 2007 ;     700+ words ... ... TM) V Everolimus Eluting Coronary Stent System has launched in Europe, Boston Scientific ... TM) Everolimus-Eluting Coronary Stent System is designed, studied and manufactured ... secured CE mark and launched the XIENCE V stent system in Europe in October 2006, and it is ...

Article: Abbott Begins Early International Launch of XIENCE(TM) V ...
PR Newswire Europe;  October 3, 2006 ;     700+ words ... ... TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery ... original projections. The XIENCE V stent system will be launched in the majority of ... ZoMaxx(TM) Drug-Eluting Coronary Stent System. The positive, differentiating clinical ...

Article: Boston Scientific Announces European Approval for World's First ...
PR Newswire Europe;  September 8, 2005 ;     700+ words ... ... Liberte(TM) paclitaxel-eluting stent system, the world's first next-generation drug-eluting stent system. The Company plans to launch the ... our next-generation drug-eluting stent system," said Paul LaViolette, Chief Operating ...

Article: Devax Initiates First Drug-Coated Stent Clinical Trial for a ...
Business Wire;  July 21, 2004 ;     700+ words ... ... initiation of the AXXESS(TM) PLUS Clinical Study for the company's AXXESS Drug-Coated Stent System ("AXXESS Stent System"). The AXXESS Stent System is the first bifurcated stent design to elute an anti-restenonic drug. The AXXESS PLUS ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives